ROSSMAX (4121.TWO) monthly revenue, September 2026
ROSSMAX reported revenue of NT$0.33bn for September 2026, down 1.1% from the previous month and up 9.2% from a year earlier. Year-to-date revenue was NT$2.87bn, up 0.8% year on year. It ranked 82 of 159 companies in the Biotechnology and Medical Care industry by year-on-year growth.
| Month | Revenue NT$bn | MoM % | YoY % |
|---|---|---|---|
| September 2026 | 0.33 | -1.1 | 9.2 |